Residue 2 of TIMP-1 is a major determinant of affinity and specificity for matrix metalloproteinases but effects of substitutions do not correlate with those of the corresponding P1′ residue of substrate

被引:68
作者
Meng, Q
Malinovskii, V
Huang, W
Hu, YJ
Chung, L
Nagase, H
Bode, W
Maskos, K
Brew, K
机构
[1] Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA
[2] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS USA
[3] Max Planck Inst Biochem, Abt Strukturforsch, D-82152 Martinsried, Germany
关键词
D O I
10.1074/jbc.274.15.10184
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The unregulated activities of matrix metalloproteinases (MMPs) are implicated in disease processes including arthritis and tumor cell invasion and metastasis, NMP activities are controlled by four homologous endogenous protein inhibitors, tissue inhibitors of metalloproteinases (TIMPs), yet different TIMPs show little specificity for individual MMPs. The large interaction interface in the TIMP-1.MMP-3 complex includes a contiguous region of TIMP-1 around the disulfide bond between Cys(1) and Cys(70) that inserts into the active site of MMP-3. The effects of fifteen different substitutions for threonine 2 of this region reveal that this residue makes a large contribution to the stability of complexes with MMPs and has a dominant influence on the specificity for different MMPs. The size, charge, and hydrophobicity of residue 2 are key factors in the specificity of TIMP. Threonine 2 of TIMP-1 interacts with the S1' specificity pocket of MMP-3, which is a key to substrate specificity, but the structural requirements in TIMP-1 residue 2 for MMP binding differ greatly from those for the corresponding residue of a peptide substrate. These results demonstrate that TIMP variants with substitutions for Thr(2) represent suitable starting points for generating more targeted TIMPs for investigation and for intervention in MMP-related diseases.
引用
收藏
页码:10184 / 10189
页数:6
相关论文
共 37 条
[1]  
AnandApte B, 1997, INVEST OPHTH VIS SCI, V38, P817
[2]   Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP4) to the COOH-terminal hemopexin-like domain of human gelatinase A - TIMP-4 binds progelatinase A and the COOH-terminal domain in a similar manner to TIMP-2 [J].
Bigg, HF ;
Shi, YE ;
Liu, YLE ;
Steffensen, B ;
Overall, CM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (24) :15496-15500
[3]   CDNA CLONING AND EXPRESSION OF A METALLOPROTEINASE INHIBITOR RELATED TO TISSUE INHIBITOR OF METALLOPROTEINASES [J].
BOONE, TC ;
JOHNSON, MJ ;
DECLERCK, YA ;
LANGLEY, KE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (07) :2800-2804
[4]   A HOT-SPOT OF BINDING-ENERGY IN A HORMONE-RECEPTOR INTERFACE [J].
CLACKSON, T ;
WELLS, JA .
SCIENCE, 1995, 267 (5196) :383-386
[5]   SEQUENCE OF HUMAN-TISSUE INHIBITOR OF METALLOPROTEINASES AND ITS IDENTITY TO ERYTHROID-POTENTIATING ACTIVITY [J].
DOCHERTY, AJP ;
LYONS, A ;
SMITH, BJ ;
WRIGHT, EM ;
STEPHENS, PE ;
HARRIS, TJR ;
MURPHY, G ;
REYNOLDS, JJ .
NATURE, 1985, 318 (6041) :66-69
[6]   Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor [J].
Fernandez-Catalan, C ;
Bode, W ;
Huber, R ;
Turk, D ;
Calvete, JJ ;
Lichte, A ;
Tschesche, H ;
Maskos, K .
EMBO JOURNAL, 1998, 17 (17) :5238-5248
[7]   Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1 [J].
GomisRuth, FX ;
Maskos, K ;
Betz, M ;
Bergner, A ;
Huber, R ;
Suzuki, K ;
Yoshida, N ;
Nagase, H ;
Brew, K ;
Bourenkov, GP ;
Bartunik, H ;
Bode, W .
NATURE, 1997, 389 (6646) :77-81
[8]   Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4 [J].
Greene, J ;
Wang, MS ;
Liu, YLE ;
Raymond, LA ;
Rosen, C ;
Shi, YNE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (48) :30375-30380
[9]  
HAYAKAWA T, 1994, J CELL SCI, V107, P2373
[10]   GROWTH-PROMOTING ACTIVITY OF TISSUE INHIBITOR OF METALLOPROTEINASES-1 (TIMP-1) FOR A WIDE-RANGE OF CELLS - A POSSIBLE NEW GROWTH-FACTOR IN SERUM [J].
HAYAKAWA, T ;
YAMASHITA, K ;
TANZAWA, K ;
UCHIJIMA, E ;
IWATA, K .
FEBS LETTERS, 1992, 298 (01) :29-32